Professional Summary
Professional Overview
Stuart Heminway is a seasoned regulatory affairs executive with over 20 years of experience in the biopharmaceutical industry. As the Senior Vice President of Regulatory Affairs at BridgeBio Cardiorenal, he oversees the company's regulatory strategy and compliance, driving the successful development and approval of innovative therapies.
Experience Summary
Current Role
In his current role as Senior Vice President of Regulatory Affairs at BridgeBio Cardiorenal, Stuart is responsible for leading the company's regulatory affairs function. He develops and implements comprehensive regulatory strategies to support the advancement of BridgeBio's pipeline of cardiorenal therapies, ensuring compliance with all relevant regulations and guidelines. Under his leadership, the regulatory affairs team has successfully navigated the complex regulatory landscape, enabling the advancement of multiple drug candidates through clinical development and regulatory review.
Career Progression
Prior to joining BridgeBio, Stuart held various regulatory affairs leadership positions at prominent biopharmaceutical companies. As the Head of North American Regulatory Affairs at Aimmune Therapeutics, he played a pivotal role in securing regulatory approvals for the company's food allergy treatments. At MyoKardia, he served as the Executive Director and Head of Regulatory Affairs, guiding the development and regulatory strategies for the company's cardiovascular drug candidates. Earlier in his career, Stuart held regulatory affairs roles at Portola Pharmaceuticals, AstraZeneca, and Bristol-Myers Squibb Medical Imaging, where he gained extensive experience in navigating the complex regulatory environment and driving the successful advancement of pharmaceutical products.
Academic Background
Stuart holds a Bachelor of Science degree in Pharmaceutical Sciences from the University of Connecticut, where he graduated with distinction.
Areas of Expertise
- Regulatory strategy development and implementation
- Navigating complex regulatory landscapes
- Collaborating with regulatory authorities (FDA, EMA, etc.)
- Cross-functional team leadership and collaboration
- Strategic planning and project management
- Cardiovascular and cardiorenal drug development
Professional Impact
Throughout his career, Stuart has demonstrated a strong track record of success in leading regulatory affairs teams and driving the successful advancement of innovative pharmaceutical products. His expertise in regulatory strategy and his ability to navigate the complex regulatory environment have been instrumental in securing approvals for multiple therapies, ultimately improving patient access to life-changing treatments. As the Senior Vice President of Regulatory Affairs at BridgeBio Cardiorenal, Stuart continues to leverage his vast experience and strategic vision to support the development and commercialization of the company's cardiorenal pipeline, further solidifying his position as a respected leader in the biopharmaceutical industry.
